Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Biopharmaceutical company developing therapeutics to treat inflammatory and infectious diseases
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |